{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:59Z","timestamp":1772166359249,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council","doi-asserted-by":"crossref","award":["RGPIN-2023-03302"],"award-info":[{"award-number":["RGPIN-2023-03302"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BioData Mining"],"DOI":"10.1186\/s13040-025-00444-x","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T16:25:12Z","timestamp":1746203112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Learning the therapeutic targets of acute myeloid leukemia through multiscale human interactome network and community analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Suruthy","family":"Sivanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fmed.2017.00211","volume":"4","author":"V Andresen","year":"2017","unstructured":"Andresen V, Gjertsen BT. Drug repurposing for the treatment of acute myeloid leukemia. Front Med. 2017;4:211.","journal-title":"Front Med."},{"issue":"2","key":"444_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/cancers12020441","volume":"12","author":"AV Wojcicki","year":"2020","unstructured":"Wojcicki AV, Kadapakkam M, Frymoyer A, Lacayo N, Chae HD, Sakamoto KM. Repurposing drugs for acute myeloid leukemia: A worthy cause or a futile pursuit? Cancers. 2020;12(2):441.","journal-title":"Cancers."},{"key":"444_CR3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/OTT.S191621","volume":"12","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gu Y, Chen B. Mechanisms of drug resistance in acute myeloid leukemia. OncoTargets Ther. 2019;12:1937.","journal-title":"OncoTargets Ther."},{"key":"444_CR4","doi-asserted-by":"crossref","unstructured":"Niu J, Peng D, Liu L. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. Front Oncol. 2022;12:896426.","DOI":"10.3389\/fonc.2022.896426"},{"key":"444_CR5","doi-asserted-by":"publisher","first-page":"659253","DOI":"10.3389\/fonc.2021.659253","volume":"11","author":"N Van Gils","year":"2021","unstructured":"Van Gils N, Denkers F, Smit L. Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia. Front Oncol. 2021;11:659253.","journal-title":"Front Oncol."},{"issue":"1","key":"444_CR6","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41467-021-21770-8","volume":"12","author":"C Ruiz","year":"2021","unstructured":"Ruiz C, Zitnik M, Leskovec J. Identification of disease treatment mechanisms through the multiscale interactome. Nat Commun. 2021;12(1):1796.","journal-title":"Nat Commun."},{"key":"444_CR7","doi-asserted-by":"crossref","unstructured":"Yang J, McAuley J, Leskovec J. Detecting cohesive and 2-mode communities indirected andundirected networks. In Proceedings of the 7th ACM international conference on Web search and data mining. 2014 (pp. 323-332).","DOI":"10.1145\/2556195.2556243"},{"issue":"1","key":"444_CR8","first-page":"2544","volume":"9","author":"M Zitnik","year":"2018","unstructured":"Zitnik M, Sosi\u010d R, Leskovec J. Prioritizing network communities Nat Commun. 2018;9(1):2544.","journal-title":"Prioritizing network communities. Nat Commun."},{"issue":"11","key":"444_CR9","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res."},{"key":"444_CR10","doi-asserted-by":"crossref","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et\u00a0al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34(suppl_1):D668\u201372.","DOI":"10.1093\/nar\/gkj067"},{"issue":"10","key":"444_CR11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cellsig.2010.05.012","volume":"22","author":"N El Zein","year":"2010","unstructured":"El Zein N, D\u2019Hondt S, Sariban E. Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation. Cell Signal. 2010;22(10):1437\u201347.","journal-title":"Cell Signal."},{"issue":"9","key":"444_CR12","first-page":"2028","volume":"113","author":"Z Li","year":"2009","unstructured":"Li Z, Beutel G, Rhein M, Meyer J, Koenecke C, Neumann T, et al. High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood J Am Soc Hematol. 2009;113(9):2028\u201337.","journal-title":"Blood J Am Soc Hematol."},{"issue":"1","key":"444_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-016-0294-x","volume":"9","author":"H Mahmud","year":"2016","unstructured":"Mahmud H, Kornblau SM, Ter Elst A, Scherpen FJ, Qiu YH, Coombes KR, et al. Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia. J Hematol Oncol. 2016;9(1):1\u20133.","journal-title":"J Hematol Oncol."},{"key":"444_CR14","doi-asserted-by":"crossref","unstructured":"da\u00a0Rocha JF, Bastos L, Domingues SC, Bento AR, Konietzko U, da\u00a0Cruz E\u00a0Silva OA, et\u00a0al. APP binds to the EGFR ligands HB-EGF and EGF, acting synergistically with EGF to promote ERK signaling and neuritogenesis. Mol Neurobiol. 2021;58:668\u201388.","DOI":"10.1007\/s12035-020-02139-2"},{"key":"444_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s13277-012-0589-7","volume":"34","author":"L Jiang","year":"2013","unstructured":"Jiang L, Yu G, Meng W, Wang Z, Meng F, Ma W. Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2. Tumor Biol. 2013;34:629\u201336.","journal-title":"Tumor Biol."},{"issue":"2","key":"444_CR16","first-page":"2034","volume":"18","author":"L Jiang","year":"2019","unstructured":"Jiang L, Meng W, Yu G, Yin C, Wang Z, Liao L, et al. MicroRNA-144 targets APP to regulate AML1\/ETO+ leukemia cell migration via the p-ERK\/c-Myc\/MMP-2 pathway. Oncol Lett. 2019;18(2):2034\u201342.","journal-title":"Oncol Lett."},{"key":"444_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01025-7","volume":"14","author":"SE Ahmadi","year":"2021","unstructured":"Ahmadi SE, Rahimi S, Zarandi B, Chegeni R, Safa M. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. J Hematol Oncol. 2021;14:1\u201349.","journal-title":"J Hematol Oncol."},{"issue":"2","key":"444_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5152\/eurasianjmed.2022.21102","volume":"54","author":"CY Kahraman","year":"2022","unstructured":"Kahraman CY, Sincan G, Tatar A. Next-Generation Sequencing Panel Test in Myeloid Neoplasms and Evaluation with the Clinical Results. Eurasian J Med. 2022;54(2):181.","journal-title":"Eurasian J Med."},{"issue":"1","key":"444_CR19","doi-asserted-by":"publisher","first-page":"2131751","DOI":"10.1080\/09537104.2022.2131751","volume":"34","author":"N Cooper","year":"2023","unstructured":"Cooper N, Ghanima W, Hill QA, Nicolson PL, Markovtsov V, Kessler C. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib. Platelets. 2023;34(1):2131751.","journal-title":"Platelets."},{"issue":"23","key":"444_CR20","doi-asserted-by":"publisher","first-page":"14706","DOI":"10.3390\/ijms232314706","volume":"23","author":"MK Bratt\u00e5s","year":"2022","unstructured":"Bratt\u00e5s MK, Hemsing AL, Rye KP, Hatfield KJ, Reikvam H. Heterogeneity of Patient-Derived Acute Myeloid Leukemia Cells Subjected to SYK In Vitro Inhibition. Int J Mol Sci. 2022;23(23):14706.","journal-title":"Int J Mol Sci."},{"issue":"11","key":"444_CR21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41419-020-03156-8","volume":"11","author":"A Polak","year":"2020","unstructured":"Polak A, Bialopiotrowicz E, Krzymieniewska B, Wozniak J, Stojak M, Cybulska M, et al. SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism. Cell Death Dis. 2020;11(11):956.","journal-title":"Cell Death Dis."},{"issue":"1","key":"444_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-021-01431-w","volume":"23","author":"M Lain\u00e9","year":"2021","unstructured":"Lain\u00e9 M, Fanning SW, Chang YF, Green B, Greene ME, Komm B, et al. Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer. Breast Cancer Res. 2021;23(1):54.","journal-title":"Breast Cancer Res."},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s12325-010-0081-y","volume":"27","author":"VJ Swan","year":"2010","unstructured":"Swan VJ, Hamilton CJ, Jamal SA. Lasofoxifene in osteoporosis and its place in therapy. Adv Ther. 2010;27:917\u201332.","journal-title":"Adv Ther."},{"key":"444_CR24","doi-asserted-by":"crossref","unstructured":"Andersson A, T\u00f6rnqvist AE, Moverare-Skrtic S, Bernardi AI, Farman HH, Chambon P, et al. Roles of activating functions 1 and 2 of estrogen receptor $$\\alpha$$ in lymphopoiesis. J Endocrinol. 2018;236(2):99\u2013109.","DOI":"10.1530\/JOE-17-0372"},{"key":"444_CR25","doi-asserted-by":"crossref","unstructured":"Mal R, Magner A, David J, Datta J, Vallabhaneni M, Kassem M, et al. Estrogen receptor beta (ER$$\\beta$$): a ligand activated tumor suppressor. Front Oncol. 2020;10:587386.","DOI":"10.3389\/fonc.2020.587386"},{"key":"444_CR26","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.compbiomed.2023.107753","volume":"168","author":"Z Liu","year":"2024","unstructured":"Liu Z, Wong HM, Chen X, Lin J, Zhang S, Yan S, et al. MotifHub: Detection of trans-acting DNA motif group with probabilistic modeling algorithm. Comput Biol Med. 2024;168:107753.","journal-title":"Comput Biol Med."},{"issue":"8","key":"444_CR27","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1093\/nar\/gkae210","volume":"52","author":"N Chen","year":"2024","unstructured":"Chen N, Yu J, Liu Z, Meng L, Li X, Wong KC. Discovering DNA shape motifs with multiple DNA shape features: generalization, methods, and validation. Nucleic Acids Res. 2024;52(8):4137\u201350.","journal-title":"Nucleic Acids Res."},{"key":"444_CR28","doi-asserted-by":"publisher","first-page":"109922","DOI":"10.1016\/j.biopha.2020.109922","volume":"125","author":"Z Ma","year":"2020","unstructured":"Ma Z, Xia Y, Hu C, Yu M, Yi H. Quercetin promotes the survival of granulocytic myeloid-derived suppressor cells via the ESR2\/STAT3 signaling pathway. Biomed Pharmacother. 2020;125:109922.","journal-title":"Biomed Pharmacother."},{"issue":"4","key":"444_CR29","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/cancers12040907","volume":"12","author":"A Roma","year":"2020","unstructured":"Roma A, Spagnuolo PA. Estrogen receptors alpha and beta in acute myeloid leukemia. Cancers. 2020;12(4):907.","journal-title":"Cancers."},{"issue":"14","key":"444_CR30","doi-asserted-by":"publisher","first-page":"6853","DOI":"10.3390\/app12146853","volume":"12","author":"N Rehman","year":"2022","unstructured":"Rehman N, Khan S, Manzoor S, Abubakar M, Sami R, Alharthy SA, et al. Estrogen Induces c-myc Transcription by Binding to Upstream ERE Element in Promoter. Appl Sci. 2022;12(14):6853.","journal-title":"Appl Sci."},{"key":"444_CR31","doi-asserted-by":"crossref","unstructured":"Rota SG, Roma A, Dude I, Ma C, Stevens R, MacEachern J, et al. Estrogen receptor \u03b2 is a novel target in acute myeloid leukemia. Mol Cancer Ther. 2017;16(11):2618\u201326.","DOI":"10.1158\/1535-7163.MCT-17-0292"},{"key":"444_CR32","doi-asserted-by":"crossref","unstructured":"Ning R, Chen G, Fang R, Zhang Y, Zhao W, Qian F. Diosmetin inhibits cell proliferation and promotes apoptosis through STAT3\/c-Myc signaling pathway in human osteosarcoma cells. Biol Res. 2021;54.","DOI":"10.1186\/s40659-021-00363-1"},{"issue":"5","key":"444_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1677\/JME-09-0134","volume":"44","author":"F Giannone","year":"2010","unstructured":"Giannone F, Malpeli G, Lisi V, Grasso S, Shukla P, Ramarli D, et al. The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis. J Mol Endocrinol. 2010;44(5):259\u201369.","journal-title":"J Mol Endocrinol."},{"key":"444_CR34","doi-asserted-by":"publisher","unstructured":"Salter DM. 8 - Connective tissue responses to mechanical stress. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology (Sixth Edition). 6th ed. Philadelphia: Mosby; 2015. pp. 61\u201364. https:\/\/doi.org\/10.1016\/B978-0-323-09138-1.00008-5.","DOI":"10.1016\/B978-0-323-09138-1.00008-5"},{"key":"444_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2019.03.054","volume":"854","author":"CE Scott","year":"2019","unstructured":"Scott CE, Tang Y, Alt A, Burford NT, Gerritz SW, Ogawa LM, et al. Identification and biochemical analyses of selective CB2 agonists. Eur J Pharmacol. 2019;854:1\u20138.","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"444_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.bbrc.2013.11.071","volume":"443","author":"P Kumar","year":"2014","unstructured":"Kumar P, Song ZH. CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene. Biochem Biophys Res Commun. 2014;443(1):144\u20139.","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"444_CR37","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1182\/blood-2003-12-4357","volume":"104","author":"M Alberich Jorda","year":"2004","unstructured":"Alberich Jorda M, Rayman N, Tas M, Verbakel SE, Battista N, Van Lom K, et al. The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. Blood. 2004;104(2):526\u201334.","journal-title":"Blood."},{"issue":"6","key":"444_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12263-014-0436-0","volume":"9","author":"G Leoni","year":"2014","unstructured":"Leoni G, Rosato A, Perozzi G, Murgia C. Zinc proteome interaction network as a model to identify nutrient-affected pathways in human pathologies. Genes Nutr. 2014;9(6):1\u20139.","journal-title":"Genes Nutr."},{"issue":"5","key":"444_CR39","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3390\/ijms23052567","volume":"23","author":"MI Costa","year":"2022","unstructured":"Costa MI, Lapa BS, Jorge J, Alves R, Carreira IM, Sarmento-Ribeiro AB, et al. Zinc prevents DNA damage in normal cells but shows genotoxic and cytotoxic effects in acute myeloid leukemia cells. Int J Mol Sci. 2022;23(5):2567.","journal-title":"Int J Mol Sci."},{"key":"444_CR40","doi-asserted-by":"crossref","unstructured":"Nathani S, Mishra R, Katiyar P, Sircar D, Roy P. Zinc acts synergistically with berberine forenhancing its efficacy as an anti-cancer agent by inducing clusterin-dependent apoptosis in HT-29 colorectal cancer cells. Biol Trace Elem Res. 2022;201:3755\u20133773.","DOI":"10.1007\/s12011-022-03460-8"},{"key":"444_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnmol.2017.00021","volume":"10","author":"K Wild","year":"2017","unstructured":"Wild K, August A, Pietrzik CU, Kins S. Structure and synaptic function of metal binding to the amyloid precursor protein and its proteolytic fragments. Front Mol Neurosci. 2017;10:21.","journal-title":"Front Mol Neurosci."},{"key":"444_CR42","doi-asserted-by":"crossref","unstructured":"Oh SB, Kim JA, Park S, Lee JY. Associative interactions among zinc, apolipoprotein E, and amyloid-$$\\beta$$ in the amyloid pathology. Int J Mol Sci. 2020;21(3):802.","DOI":"10.3390\/ijms21030802"},{"key":"444_CR43","doi-asserted-by":"publisher","unstructured":"Ubuka T. Subchapter 132A - Glutamic acid. In: Ando H, Ukena K, Nagata S, editors. Handbook of Hormones (Second Edition). second edition ed. San Diego: Academic Press; 2021. pp. 1063\u20131065. https:\/\/doi.org\/10.1016\/B978-0-12-820649-2.00296-5.","DOI":"10.1016\/B978-0-12-820649-2.00296-5"},{"key":"444_CR44","doi-asserted-by":"publisher","first-page":"694526","DOI":"10.3389\/fonc.2021.694526","volume":"11","author":"A Bhingarkar","year":"2021","unstructured":"Bhingarkar A, Vangapandu HV, Rathod S, Hoshitsuki K, Fernandez CA. Amino acid metabolic vulnerabilities in acute and chronic myeloid leukemias. Front Oncol. 2021;11:694526.","journal-title":"Front Oncol."},{"issue":"10","key":"444_CR45","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1878-0261.12999","volume":"15","author":"P Kandasamy","year":"2021","unstructured":"Kandasamy P, Zlobec I, Nydegger DT, Pujol-Gim\u00e9nez J, Bhardwaj R, Shirasawa S, et al. Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1. Mol Oncol. 2021;15(10):2782\u2013800.","journal-title":"Mol Oncol."},{"issue":"48","key":"444_CR46","doi-asserted-by":"publisher","first-page":"18782","DOI":"10.1073\/pnas.0810199105","volume":"105","author":"DR Wise","year":"2008","unstructured":"Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci. 2008;105(48):18782\u20137.","journal-title":"Proc Natl Acad Sci."},{"issue":"1","key":"444_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4062\/biomolther.2015.078","volume":"24","author":"N Wu","year":"2016","unstructured":"Wu N, Yang M, Gaur U, Xu H, Yao Y, Li D. Alpha-ketoglutarate: physiological functions and applications. Biomol Ther. 2016;24(1):1.","journal-title":"Biomol Ther."},{"issue":"1","key":"444_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-022-01339-8","volume":"15","author":"D Kunadt","year":"2022","unstructured":"Kunadt D, Stasik S, Metzeler KH, R\u00f6llig C, Schliemann C, Greif PA, et al. Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation. J Hematol Oncol. 2022;15(1):1\u201315.","journal-title":"J Hematol Oncol."},{"issue":"6","key":"444_CR49","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41408-021-00497-1","volume":"11","author":"GC Issa","year":"2021","unstructured":"Issa GC, DiNardo CD. Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm. Blood Cancer J. 2021;11(6):107.","journal-title":"Blood Cancer J."},{"issue":"7390","key":"444_CR50","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature. 2012;483(7390):474\u20138.","journal-title":"Nature."},{"key":"444_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s10015-014-0178-5","volume":"19","author":"T Hase","year":"2014","unstructured":"Hase T, Kikuchi K, Ghosh S, Kitano H, Tanaka H. Identification of drug-target modules in the human protein-protein interaction network. Artif Life Robot. 2014;19:406\u201313.","journal-title":"Artif Life Robot."}],"updated-by":[{"DOI":"10.1186\/s13040-025-00451-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000}}],"container-title":["BioData Mining"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13040-025-00444-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13040-025-00444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T06:01:47Z","timestamp":1747893707000},"score":1,"resource":{"primary":{"URL":"https:\/\/biodatamining.biomedcentral.com\/articles\/10.1186\/s13040-025-00444-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s13040-025-00444-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4803409\/v1","asserted-by":"object"}]},"ISSN":["1756-0381"],"issn-type":[{"value":"1756-0381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13040-025-00451-y","URL":"https:\/\/doi.org\/10.1186\/s13040-025-00451-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}